Towards the emerging crosstalk: ERBB family and steroid hormones.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Seminars in Cell and Developmental Biology

• Publication date

  2016-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.semcdb.2015.11.004PMID 26582250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progesterone receptor modulates estrogen receptor-α action in breast cancer

  2015cited by this paper
• Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancy

  2015cited by this paper
• The key roles of ERBB2 in cardiac regeneration

  2015cited by this paper
• Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis

  2015cited by this paper
• ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation

  2015cited by this paper
• Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment

  2014cited by this paper
• Frequent promoter hypermethylation and expression reduction of the glucocorticoid receptor gene in breast tumors

  2014cited by this paper
• Positive Feedback Within a Kinase Signaling Complex Functions as a Switch Mechanism for NF-κB Activation

  2014cited by this paper
• Phosphorylation: a fundamental regulator of steroid receptor action.

  2013cited by this paper
• Encoding and decoding cellular information through signaling dynamics.

  2013cited by this paper
• Mineralocorticoid receptor interaction with SP1 generates a new response element for pathophysiologically relevant gene expression

  2013cited by this paper
• Amphiregulin mediates progesterone-induced mammary ductal development during puberty

  2013cited by this paper
• Reduced Androgen Receptor Expression Accelerates the Onset of ERBB2 Induced Breast Tumors in Female Mice

  2013cited by this paper
• The Stat3/GR interaction code: predictive value of direct/indirect DNA recruitment for transcription outcome.

  2012cited by this paper
• Identification of androgen-regulated genes in human prostate

  2012cited by this paper
• The ERBB network: at last, cancer therapy meets systems biology

  2012cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012cited by this paper
• The Expression of the Glucocorticoid Receptor in Human Erythroblasts is Uniquely Regulated by KIT Ligand: Implications for Stress Erythropoiesis

  2012cited by this paper
• The Unliganded Glucocorticoid Receptor Positively Regulates the Tumor Suppressor Gene BRCA1 through GABP Beta

  2012cited by this paper
• LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer

  2011cited by this paper
• Loss of Glucocorticoid Receptor Expression by DNA Methylation Prevents Glucocorticoid Induced Apoptosis in Human Small Cell Lung Cancer Cells

  2011cited by this paper
• Progesterone Receptor Inhibits Proliferation of Human Breast Cancer Cells via Induction of MAPK Phosphatase 1 (MKP-1/DUSP1)*

  2011cited by this paper
• Targeting androgen receptor in estrogen receptor-negative breast cancer.

  2011cited by this paper
• Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor.

  2011cited by this paper
• Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer.

  2011cited by this paper
• Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling

  2011cited by this paper
• Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ERα-Positive Breast Cancer

  2011cited by this paper
• Feedback regulation of EGFR signalling: decision making by early and delayed loops

  2011cited by this paper
• Glucocorticoid suppresses BDNF‐stimulated MAPK/ERK pathway via inhibiting interaction of Shp2 with TrkB

  2011cited by this paper
• Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals.

  2011cited by this paper
• Mechanisms of endocrine resistance in breast cancer.

  2011cited by this paper
• Estrogen Receptor, Progesterone Receptor, and Glucocorticoid Receptor Expression in Normal Breast Tissue, Breast In Situ Carcinoma, and Invasive Breast Cancer

  2010cited by this paper
• A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation

  2010cited by this paper
• Aldosterone: effects on the kidney and cardiovascular system

  2010cited by this paper
• Biological determinants of endocrine resistance in breast cancer

  2009cited by this paper
• Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease

  2009cited by this paper
• DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity

  2009cited by this paper
• Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-γ signaling for glutamate release via a glutamate transporter

  2009cited by this paper
• Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines.

  2009cited by this paper
• Androgen receptor expression in prostate cancer cells is suppressed by activation of epidermal growth factor receptor and ErbB2.

  2009cited by this paper
• Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth

  2009cited by this paper
• Biological robustness

  2008cited by this paper
• Gamma-secretase inhibitors reverse glucocorticoid resistance in T-ALL

  2008cited by this paper
• Network motifs: theory and experimental approaches

  2007cited by this paper
• A module of negative feedback regulators defines growth factor signaling

  2007cited by this paper
• DUSP22/LMW-DSP2 regulates estrogen receptor-alpha-mediated signaling through dephosphorylation of Ser-118.

  2007cited by this paper
• Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage

  2007cited by this paper
• DUSP22/LMW-DSP2 regulates estrogen receptor-α-mediated signaling through dephosphorylation of Ser-118

  2007cited by this paper
• Nuclear receptors versus inflammation: mechanisms of transrepression.

  2006cited by this paper
• EGF–ERBB signalling: towards the systems level

  2006cited by this paper
• Glucocorticoid and Androgen Activation of Monoamine Oxidase A Is Regulated Differently by R1 and Sp1*

  2006cited by this paper
• Cell-signalling dynamics in time and space

  2006cited by this paper
• ADAMTS1, CRABP1, and NR3C1 Identified as Epigenetically Deregulated Genes in Colorectal Tumorigenesis

  2006cited by this paper
• Aldosterone and Angiotensin II Synergistically Induce Mitogenic Response in Vascular Smooth Muscle Cells

  2005cited by this paper
• Gene 33 Is an Endogenous Inhibitor of Epidermal Growth Factor (EGF) Receptor Signaling and Mediates Dexamethasone-induced Suppression of EGF Function*

  2005cited by this paper
• Estrogen-receptor biology: continuing progress and therapeutic implications.

  2005cited by this paper
• Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.

  2005cited by this paper
• Androgens activate mitogen‐activated protein kinase signaling: Role in neuroprotection

  2005cited by this paper
• The discovery of receptor tyrosine kinases: targets for cancer therapy

  2004cited by this paper
• Principles for modulation of the nuclear receptor superfamily

  2004cited by this paper
• Stat3 enhances transactivation of steroid hormone receptors

  2003cited by this paper
• A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects.

  2003cited by this paper
• Aldosterone Stimulates Epidermal Growth Factor Receptor Expression*

  2003cited by this paper
• Nongenomic actions of steroid hormones

  2003cited by this paper
• Combinatorial control of gene expression by nuclear receptors and coregulators.

  2002cited by this paper
• Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase

  2002cited by this paper
• Identification and characterization of a negative regulatory element within the epidermal growth factor receptor gene first intron in hormone‐dependent breast cancer cells

  2002cited by this paper
• Activation of mitogen-activated protein kinase (mitogen-activated protein kinase/extracellular signal-regulated kinase) cascade by aldosterone.

  2002cited by this paper
• Estrogen Activates Phosphatases and Antagonizes Growth-Promoting Effect of Angiotensin II

  2002cited by this paper
• Transcription factors as targets for cancer therapy

  2002cited by this paper
• Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1

  2001cited by this paper
• Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-&kgr;B Activation in Angiotensin II–Induced Cardiac Injury

  2001cited by this paper
• Oncogenic kinase signalling

  2001cited by this paper
• Glucocorticoid Receptor Interaction with 14-3-3 and Raf-1, a Proposed Mechanism for Cross-talk of Two Signal Transduction Pathways*

  2000cited by this paper
• Resetting of circadian time in peripheral tissues by glucocorticoid signaling.

  2000cited by this paper
• Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex.

  2000cited by this paper
• Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

  2000cited by this paper
• Identification of an estrogen-mediated deoxyribonucleic acid-binding independent transactivation pathway on the epidermal growth factor receptor gene promoter.

  2000cited by this paper
• Cell signaling by receptor tyrosine kinases.

  2000cited by this paper
• Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism.

  1999cited by this paper
• Dissociated Glucocorticoids with Anti-Inflammatory Potential Repress Interleukin-6 Gene Expression by a Nuclear Factor-κB-Dependent Mechanism

  1999cited by this paper
• Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells.

  1999cited by this paper
• Progesterone Regulates Transcription of the p21 WAF1 Cyclindependent Kinase Inhibitor Gene through Sp1 and CBP/p300*

  1998cited by this paper
• The discovery and early use of cortisone

  1998cited by this paper
• Convergence of Progesterone and Epidermal Growth Factor Signaling in Breast Cancer

  1998cited by this paper
• Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

  1997cited by this paper
• STAT3 Acts as a Co-activator of Glucocorticoid Receptor Signaling*

  1997cited by this paper
• Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo.

  1997cited by this paper
• Functional interactions between Stat5 and the glucocorticoid receptor

  1996cited by this paper
• Mutual Transcriptional Interference between RelA and Androgen Receptor*

  1996cited by this paper
• Negative Interaction between the RelA(p65) Subunit of NF-B and the Progesterone Receptor (*)

  1996cited by this paper
• Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells.

  1996cited by this paper
• Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

  1995cited by this paper
• Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells.

  1994cited by this paper
• Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor.

  1994cited by this paper
• Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.

  1993cited by this paper
• Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor.

  1993cited by this paper
• Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor.

  1992cited by this paper
• Role of transforming growth factor-α-related peptides in the autocrine/paracrine control of experimental breast cancer growthin vitro by estradiol, prolactin, and progesterone

  1990cited by this paper
• Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.

  1990cited by this paper

• Harnessing glucocorticoid receptor antagonism to enhance the efficacy of cardiac regenerative growth factors and cytokines

  2026cites this paper
• Neuregulin-1 reduces Doxorubicin-induced cardiotoxicity by upregulating YAP to inhibit senescence.

  2024cites this paper
• Sprouty4 at the crossroads of Trk neurotrophin receptor signaling suppression by glucocorticoids

  2023cites this paper
• Glucocorticoid Receptor Antagonism and Cardiomyocyte Regeneration following Myocardial Infarction: A Systematic Review.

  2023cites this paper
• The multifaceted nature of endogenous cardiac regeneration

  2023cites this paper
• Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment

  2022cites this paper
• Adlay Testa (Coix lachryma-jobi L. var. Ma-yuen Stapf.) Ethanolic Extract and Its Active Components Exert Anti-Proliferative Effects on Endometrial Cancer Cells via Cell Cycle Arrest

  2021cites this paper
• ANNALS OF THE NEW YORK ACADEMY OF SCIENCES MARROW

  2021cites this paper
• Extracellular vesicles from M1‐polarized macrophages promote inflammation in the temporomandibular joint via miR‐1246 activation of the Wnt/β‐catenin pathway

  2021cites this paper
• Glucocorticoid Receptor ablation promotes cardiac regeneration by hampering cardiomyocyte terminal differentiation

  2020cites this paper
• The ANKS1B gene and its associated phenotypes: focus on CNS drug response.

  2019cites this paper
• Construction and analysis of circular RNA molecular regulatory networks in clear cell renal cell carcinoma

  2019cites this paper
• Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies

  2019cites this paper
• Rapid Aldosterone-Mediated Signaling in the DCT Increases Activity of the Thiazide-Sensitive NaCl Cotransporter.

  2019cites this paper
• A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy

  2018cites this paper
• Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin.

  2018cites this paper
• Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone

  2017cites this paper
• A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors

  2016cites this paper
• Shaping ERBB Signalling by Steroid Hormones

  2016cites this paper
• Advances in plant-based inhibitors of P-glycoprotein

  2016cites this paper
• Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.

  2016cites this paper
• World Journal of Hepatology

  year unknowncites this paper